CN101342239A - Pure natural medicament for treating AIDS - Google Patents
Pure natural medicament for treating AIDS Download PDFInfo
- Publication number
- CN101342239A CN101342239A CNA2008102122563A CN200810212256A CN101342239A CN 101342239 A CN101342239 A CN 101342239A CN A2008102122563 A CNA2008102122563 A CN A2008102122563A CN 200810212256 A CN200810212256 A CN 200810212256A CN 101342239 A CN101342239 A CN 101342239A
- Authority
- CN
- China
- Prior art keywords
- percent
- powder
- hiv
- pure natural
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 20
- 208000030507 AIDS Diseases 0.000 title claims description 20
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 10
- 235000008434 ginseng Nutrition 0.000 claims abstract description 10
- 230000036737 immune function Effects 0.000 claims abstract description 8
- 241001655769 Androsace Species 0.000 claims abstract description 7
- 241000196324 Embryophyta Species 0.000 claims abstract description 6
- 241001465754 Metazoa Species 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- 239000000843 powder Substances 0.000 claims description 18
- 238000005303 weighing Methods 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 10
- 241000208340 Araliaceae Species 0.000 claims description 9
- 241000965254 Apostichopus japonicus Species 0.000 claims description 8
- 208000011580 syndromic disease Diseases 0.000 claims description 8
- 230000000840 anti-viral effect Effects 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- 238000011049 filling Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 241000628997 Flos Species 0.000 claims description 3
- 241000271915 Hydrophis Species 0.000 claims description 3
- 241000237636 Pheretima Species 0.000 claims description 3
- 241000195474 Sargassum Species 0.000 claims description 3
- 241000522620 Scorpio Species 0.000 claims description 3
- 206010047700 Vomiting Diseases 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 239000007902 hard capsule Substances 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 238000011068 loading method Methods 0.000 claims description 3
- 239000012567 medical material Substances 0.000 claims description 3
- 238000005325 percolation Methods 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 230000003068 static effect Effects 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 230000008673 vomiting Effects 0.000 claims description 3
- 239000010231 banlangen Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 239000009490 scorpio Substances 0.000 claims description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 3
- 210000004369 blood Anatomy 0.000 abstract description 3
- 206010061598 Immunodeficiency Diseases 0.000 abstract description 2
- 208000029462 Immunodeficiency disease Diseases 0.000 abstract description 2
- 241000133430 Tinospora Species 0.000 abstract description 2
- 210000000987 immune system Anatomy 0.000 abstract description 2
- 230000007813 immunodeficiency Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241001474374 Blennius Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 241000251511 Holothuroidea Species 0.000 abstract 1
- 241000271899 Hydrophis cyanocinctus Species 0.000 abstract 1
- 241000334154 Isatis tinctoria Species 0.000 abstract 1
- 241000245050 Menispermum Species 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 239000009910 sargent gloryvine Substances 0.000 abstract 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 16
- 230000000694 effects Effects 0.000 description 7
- 241000700605 Viruses Species 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000031886 HIV Infections Diseases 0.000 description 2
- 208000037357 HIV infectious disease Diseases 0.000 description 2
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 2
- 208000030208 low-grade fever Diseases 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- HBOMLICNUCNMMY-XLPZGREQSA-N zidovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-XLPZGREQSA-N 0.000 description 2
- 229960002555 zidovudine Drugs 0.000 description 2
- UPLPHRJJTCUQAY-WIRWPRASSA-N 2,3-thioepoxy madol Chemical compound C([C@@H]1CC2)[C@@H]3S[C@@H]3C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@](C)(O)[C@@]2(C)CC1 UPLPHRJJTCUQAY-WIRWPRASSA-N 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 241000245240 Lonicera Species 0.000 description 1
- 208000001388 Opportunistic Infections Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000501098 Sargentodoxa Species 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000036436 anti-hiv Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008102122563A CN101342239B (en) | 2008-09-08 | 2008-09-08 | Pure natural medicament for treating AIDS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008102122563A CN101342239B (en) | 2008-09-08 | 2008-09-08 | Pure natural medicament for treating AIDS |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101342239A true CN101342239A (en) | 2009-01-14 |
CN101342239B CN101342239B (en) | 2012-05-23 |
Family
ID=40244430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008102122563A Expired - Fee Related CN101342239B (en) | 2008-09-08 | 2008-09-08 | Pure natural medicament for treating AIDS |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101342239B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101569408B (en) * | 2009-04-23 | 2012-12-26 | 湛江市贤博科技有限公司 | Pure nature food for improving human health |
CN101569407B (en) * | 2009-04-23 | 2013-10-16 | 湛江市贤博科技有限公司 | Pure nature food for improving human body function |
WO2015130251A1 (en) | 2014-02-26 | 2015-09-03 | Bülbül Şevger | Manufacturing method of a natural composition formed of the offal meats for the recovery of aids illness |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1212870A (en) * | 1997-09-30 | 1999-04-07 | 刘建安 | Oral liquid for anti-AIDS and venereal disease |
CN1839987A (en) * | 2006-01-19 | 2006-10-04 | 张连波 | AIDS resistant medicine- porcher capsule and production technology |
-
2008
- 2008-09-08 CN CN2008102122563A patent/CN101342239B/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101569408B (en) * | 2009-04-23 | 2012-12-26 | 湛江市贤博科技有限公司 | Pure nature food for improving human health |
CN101569407B (en) * | 2009-04-23 | 2013-10-16 | 湛江市贤博科技有限公司 | Pure nature food for improving human body function |
WO2015130251A1 (en) | 2014-02-26 | 2015-09-03 | Bülbül Şevger | Manufacturing method of a natural composition formed of the offal meats for the recovery of aids illness |
Also Published As
Publication number | Publication date |
---|---|
CN101342239B (en) | 2012-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109674958A (en) | A kind of Chinese medicine composition and its preparation method and application with anti-trioxypurine | |
CN101357219A (en) | Medicine for treating chronic hepatitis b | |
CN105079226A (en) | Application of traditional Chinese medicine composition to preparation of drug for resisting Middle East respiratory syndrome corona-virus (MERS-CoV) | |
CN103446525B (en) | Treat dermopathic Chinese medicine composition and its preparation method and application | |
CN101773527A (en) | Pinecone extractive of Yunnan Pinus and preparation method and medicinal application thereof | |
CN101342239B (en) | Pure natural medicament for treating AIDS | |
CN103585561B (en) | A kind of Chinese medicine composition for the treatment of gout | |
CN103223069A (en) | Traditional Chinese medicine composition for treating hepatitis | |
CN101683423B (en) | Application of Chinese medicine composition in preparation of medicament for treating chicken pox | |
CN102908443B (en) | Medicinal composition for therapy or adjuvant therapy of aids, preparation method of medicinal composition and application of medicinal composition | |
CN102895399A (en) | Natural drug for treating human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) | |
WO1993013787A1 (en) | Immunopotentiating agent | |
CN105497126A (en) | Chinese medicinal composition for treating piglet epidemic diarrhea | |
CN101559114A (en) | Application of traditional Chinese medicine composition in preparing antihypoxic | |
CN101926948A (en) | Uigur medicament for treating AIDS and preparation method thereof | |
CN103505500B (en) | A kind of Chinese medicine composition for the treatment of hepatitis B and preparation method thereof | |
CN103191386B (en) | Medicament for treating chronic hepatitis B | |
CN108815358A (en) | It is a kind of prevent and treat Hashimoto thyroiditis Chinese medicine and its application | |
CN101537150B (en) | Medicine for treating pulmonary tuberculosis | |
CN100443093C (en) | AIDS treating medicine | |
CN101607009B (en) | Pharmaceutical composition for treating cold | |
CN101543615A (en) | Method for preparing Chinese medicinal combination for treating gall-stone | |
CN101491574A (en) | Traditional Chinese medicine compound recipe for treating chronic hepatitis-B and preparation method thereof | |
CN101152262A (en) | Anti-gout novel medical preparation | |
CN104225014B (en) | A kind of Tibetan medicine for the treatment of diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: ZHANGJIANG XIANBO SCIENCE + TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: MO YIXIAN Effective date: 20110131 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 524044 NO.91 (ZHANJIANG XIANBO TECHNOLOGY CO., LTD.), NORTH OF HAIBIN AVENUE, ZHANJIANG CITY, GUANGDONG PROVINCE TO: 524044 ROOM 806, NO.61, SOUTH OF HAIBIN AVENUE, DEVELOPMENT AREA, ZHANJIANG CITY, GUANGDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20110131 Address after: 806, room 61, 524044, Haibin Avenue, Zhanjiang Development Zone, Guangdong, China Applicant after: Zhanjiang Xianbo Technology Co., Ltd. Address before: 524044, No. 91, Haibin Avenue, Zhanjiang City, Guangdong province (Zhanjiang Yin Bo Technology Co., Ltd.) Applicant before: Mo Yixian |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200420 Address after: Room 1115, building 1, Evergrande oasis garden, No. 12, Haiwan South Road, Potou District, Zhanjiang City, Guangdong Province Patentee after: Zhanjiang Tiantai Pharmaceutical Technology Co., Ltd Address before: 806, room 61, 524044, Haibin Avenue, Zhanjiang Development Zone, Guangdong, China Patentee before: ZHANJIANG XIANBO TECHNOLOGY Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120523 Termination date: 20200908 |